These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12445369)

  • 1. Detection of mutated K12-ras in histologically negative lymph nodes as an indicator of poor prognosis in stage II colorectal cancer.
    Belly RT; Rosenblatt JD; Steinmann M; Toner J; Sun J; Shehadi J; Peacock JL; Raubertas RF; Jani N; Ryan CK
    Clin Colorectal Cancer; 2001 Aug; 1(2):110-6. PubMed ID: 12445369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of occult metastases in sentinel lymph nodes from colon cancer patients by K-ras mutation peptide nucleic acid clamp PCR.
    Oltedal S; Gilje B; Kørner H; Aasprong OG; Tjensvoll K; Heikkilä R; Smaaland R; Nordgård O
    Ann Surg; 2010 Jun; 251(6):1087-91. PubMed ID: 20485143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenocarcinoma of the pancreas: detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay.
    Demeure MJ; Doffek KM; Komorowski RA; Wilson SD
    Cancer; 1998 Oct; 83(7):1328-34. PubMed ID: 9762933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
    Conzelmann M; Linnemann U; Berger MR
    Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.
    Sanchez-Cespedes M; Esteller M; Hibi K; Cope FO; Westra WH; Piantadosi S; Herman JG; Jen J; Sidransky D
    Clin Cancer Res; 1999 Sep; 5(9):2450-4. PubMed ID: 10499618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated colorectal tumor cells in organs prone to metastasis detected by new double enriched nested-PCR in comparison with recognized assays.
    Kraus MC; Linnemann U; Berger MR
    Oncol Rep; 2011 May; 25(5):1421-9. PubMed ID: 21369707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratin 20 is a specific marker of submicroscopic lymph node metastases in colorectal cancer: validation by K-RAS mutations.
    Yun K; Merrie AE; Gunn J; Phillips LV; McCall JL
    J Pathol; 2000 May; 191(1):21-6. PubMed ID: 10767714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations in molecular detection of lymph node micrometastasis from colorectal cancer.
    Klebig F; Fischer C; Petri S; Gerull H; Wagener C; Tschentscher P
    Diagn Mol Pathol; 2007 Jun; 16(2):91-5. PubMed ID: 17525678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases.
    Hashimoto T; Kobayashi Y; Ishikawa Y; Tsuchiya S; Okumura S; Nakagawa K; Tokuchi Y; Hayashi M; Nishida K; Hayashi S; Hayashi J; Tsuchiya E
    Cancer Res; 2000 Nov; 60(22):6472-8. PubMed ID: 11103815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction study.
    Chen G; McIver CM; Texler M; Lloyd JM; Rieger N; Hewett PJ; Sen Wan D; Hardingham JE
    Dis Colon Rectum; 2004 May; 47(5):679-86. PubMed ID: 15037935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of micrometastases after curative resection for ductal adenocarcinoma of the pancreas].
    Niedergethmann M; Rexin M; Knob S; Hartel M; Sturm JW; Richter A; Post S
    Zentralbl Chir; 2001 Nov; 126(11):917-21. PubMed ID: 11753804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemistry and molecular detection of nodal micrometastases in pancreatic cancer.
    Brown HM; Ahrendt SA; Komorowski RA; Doffek KM; Wilson SD; Demeure MJ
    J Surg Res; 2001 Feb; 95(2):141-6. PubMed ID: 11162037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Frequency and clinicopathological associations of K-ras mutations in Venezuelan patients with colo-rectal cancer].
    Estrada P; Rojas-Atencio A; Zabala W; Borjas L; Soca L; Urdaneta K; Alvarez-Nava F; Cañizales J; Rojas J; Soto M
    Invest Clin; 2009 Mar; 50(1):55-63. PubMed ID: 19418727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
    Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M
    Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
    Ahnen DJ; Feigl P; Quan G; Fenoglio-Preiser C; Lovato LC; Bunn PA; Stemmerman G; Wells JD; Macdonald JS; Meyskens FL
    Cancer Res; 1998 Mar; 58(6):1149-58. PubMed ID: 9515799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
    Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
    Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes.
    Bernini A; Spencer M; Frizelle S; Madoff RD; Willmott LD; McCormick SR; Niehans GA; Ho SB; Kratzke RA
    Cancer Detect Prev; 2000; 24(1):72-9. PubMed ID: 10757125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis.
    Sugio K; Ishida T; Yokoyama H; Inoue T; Sugimachi K; Sasazuki T
    Cancer Res; 1992 May; 52(10):2903-6. PubMed ID: 1581907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K-ras mutations are correlated to lymph node metastasis and tumor stage, but not to the growth pattern of colon carcinoma.
    Mannan A; Hahn-Strömberg V
    APMIS; 2012 Jun; 120(6):459-68. PubMed ID: 22583358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.